Profile data is unavailable for this security.
About the company
TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company operates its businesses through the distribution of proprietary drug products, as well as the processing of pharmaceuticals and others. The Company conducts its businesses primarily in South China, North China, East China, Central China and overseas markets.
- Revenue in CNY (TTM)2.93bn
- Net income in CNY810.63m
- Incorporated1999
- Employees601.00
- LocationTibet Rhodiola Pharmaceutical Holding CoNo. 19, Beijing Middle RoadLASA 850000ChinaCHN
- Phone+86 2 886653915
- Fax+86 2 886660740
- Websitehttp://www.xzyy.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NanJing Pharmaceutical Co Ltd | 53.59bn | 577.83m | 6.37bn | 4.90k | 11.05 | 0.976 | -- | 0.1188 | 0.4397 | 0.4397 | 40.75 | 4.98 | 1.78 | 8.70 | 4.11 | 10,929,970.00 | 2.37 | 2.32 | 8.06 | 8.94 | 5.98 | 6.41 | 1.33 | 1.30 | 1.09 | 2.91 | 0.6148 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Guangxi LiuYao Group Co Ltd | 21.25bn | 888.87m | 9.09bn | 5.58k | 9.27 | 1.19 | -- | 0.4279 | 2.46 | 2.46 | 58.82 | 19.12 | 1.07 | 6.99 | 1.97 | 3,807,204.00 | 4.80 | 5.06 | 11.73 | 12.21 | 11.56 | 11.85 | 4.47 | 4.40 | 1.30 | 5.26 | 0.5434 | 29.90 | 9.23 | 12.18 | 21.11 | 9.97 | -8.63 | 6.26 |
| Tibet Rhodiola Pharmaceutical Holding Co | 2.93bn | 810.63m | 11.83bn | 601.00 | 13.08 | 2.49 | -- | 4.04 | 2.81 | 2.81 | 9.65 | 14.76 | 0.6016 | 1.81 | 6.68 | 4,877,892.00 | 16.83 | 12.44 | 23.18 | 15.71 | 93.68 | 90.51 | 27.97 | 20.43 | 2.79 | 7.96 | 0.1716 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 1.11bn | -324.42m | 12.58bn | 1.95k | -- | 7.28 | -- | 11.32 | -0.6628 | -0.6628 | 2.27 | 3.53 | 0.4005 | 0.8061 | 1.31 | 569,846.60 | -12.26 | -1.17 | -16.80 | -1.67 | 69.24 | 71.94 | -30.62 | -3.27 | 1.55 | -18.71 | 0.1474 | -- | 16.44 | -3.17 | -26.08 | -- | -50.29 | -- |
| China Meheco Group Co Ltd | 40.47bn | 563.10m | 16.63bn | 8.31k | 29.54 | 1.49 | -- | 0.411 | 0.3764 | 0.3764 | 27.05 | 7.48 | 1.13 | 5.58 | 2.76 | 4,868,542.00 | 2.05 | 4.09 | 4.44 | 9.37 | 11.07 | 15.92 | 1.81 | 3.38 | 1.16 | 21.23 | 0.3262 | 38.19 | 3.75 | 4.37 | 13.70 | -10.94 | 12.63 | -4.53 |
Data as of Apr 18 2024. Currency figures normalised to Tibet Rhodiola Pharmaceutical Holding Co's reporting currency: Chinese Yuan Renminbi CNY
7.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 3.91m | 1.58% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 3.84m | 1.55% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 2.16m | 0.87% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023 | 2.09m | 0.84% |
| JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 2023 | 1.71m | 0.69% |
| Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 2023 | 1.53m | 0.62% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2023 | 1.16m | 0.47% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 995.40k | 0.40% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 846.36k | 0.34% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 727.41k | 0.29% |
More ▼
Data from 30 Jun 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
